Reata Pharmaceuticals Inc sell Global_Player
Summary
This prediction ended on 03.03.23 with a price of €82.00. The SELL prediction by Global_Player for Reata Pharmaceuticals Inc was trending in the completely wrong direction and closed with a performance of 85.52%. Global_Player has 50% into this predictionReata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on identifying, developing, and commercializing novel therapeutics for patients with severe and life-threatening diseases. The company's primary business areas include drug discovery and development in fields such as cardiovascular, fibrotic, mitochondrial, and neurodegenerative diseases. With a strong emphasis on research and innovation, Reata Pharmaceuticals seeks to deliver cutting-edge treatments that address unmet medical needs, improve patient outcomes, and significantly impact the lives of those suffering from rare and debilitating conditions. As a publicly traded company, Reata Pharmaceuticals is listed on the NASDAQ stock exchange under the ticker symbol "RETA."
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Reata Pharmaceuticals Inc | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
According to Global_Player what are the pros and cons of Reata Pharmaceuticals Inc for the foreseeable future?
Pros
Cons
Comments by Global_Player for this prediction
In the thread Reata Pharmaceuticals Inc diskutieren
In the thread Trading Reata Pharmaceuticals Inc
Stopped prediction by Global_Player for Reata Pharmaceuticals Inc
Reata Pharmaceuticals Inc
28.03.22
28.03.23
02.04.22
